Overview

• Pharmacies across the UK are rationing higher-dose Mounjaro and Wegovy as unprecedented demand exceeds available stock.
• The National Pharmacy Association is urging government to align prescribing with MHRA and NHS guidelines to prioritise eligible patients.
• New polling shows 21% of adults and 35% of 16–34-year-olds attempted to access GLP-1 injections despite strict BMI and comorbidity criteria.
• Pharmacists warn that shortages could drive patients toward unregulated online sources offering unverified or counterfeit products.
• Clinicians have documented rapid BMI declines, muscle wasting and malnutrition among unsupervised users misusing weight-loss jabs.